DSGN - Design Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.50
DETAILS
HIGH:
$21.00
LOW:
$14.00
MEDIAN:
$17.50
CONSENSUS:
$17.50
UPSIDE:
59.53%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Cost of Revenue | 0.6 | 0.6 | 0.5 | 0.5 | 0 | 0.0 | 0.0 |
| Gross Profit | (0.6) | (0.6) | (0.5) | (0.5) | 0 | (0.0) | (0.0) |
| Operating Expenses | |||||||
| R&D Expenses | 59.1 | 44.4 | 57.1 | 48.6 | 24.8 | 6.1 | 1.7 |
| SG&A Expenses | 20.3 | 18.0 | 21.1 | 19.0 | 11.1 | 2.5 | 1.1 |
| Other Expenses | (0.6) | (0.6) | (0.5) | (0.5) | 0 | 0 | (0.8) |
| Operating Expenses | 78.8 | 61.8 | 77.7 | 67.1 | 35.8 | 8.6 | 1.9 |
| Operating Income | |||||||
| Operating Income | (79.5) | (62.4) | (78.2) | (67.6) | (35.8) | (8.6) | (1.9) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 9.7 | 12.8 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | (78.8) | (49.0) | (66.3) | (62.8) | (35.7) | (8.3) | (0.1) |
| EBIT | (79.5) | (49.6) | (66.9) | (63.3) | (35.8) | (8.3) | (2.0) |
| Income Before Tax | (69.8) | (49.6) | (66.9) | (63.3) | (35.5) | (8.3) | (2.0) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (69.8) | (49.6) | (66.9) | (63.3) | (35.5) | (8.3) | (2.0) |
| Per Share Data | |||||||
| EPS (Basic) | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 | -0.30 | -0.08 |
| EPS (Diluted) | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 | -0.30 | -0.08 |
| Shares Outstanding | 57.3 | 56.6 | 56.0 | 55.7 | 45.9 | 27.2 | 27.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 16.9 | 22.6 | 21.2 | 26.5 | 298.6 | 2.4 | 0.1 |
| Short-Term Investments | 203.0 | 222.9 | 260.6 | 303.9 | 85.5 | 33.7 | 0 |
| Net Receivables | 1.7 | 1.3 | 1.4 | 1.1 | 0.1 | 0.0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 |
| Total Current Assets | 223.8 | 248.0 | 284.6 | 335.1 | 385.4 | 36.2 | 0.1 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 2.4 | 3.6 | 4.6 | 5.6 | 5.1 | 0.1 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0.4 | 0.4 | 0.5 | 0 | 0.2 | 0 |
| Total Non-Current Assets | 2.4 | 4.1 | 5.1 | 6.0 | 5.1 | 0.3 | 0 |
| Total Assets | 226.2 | 252.1 | 289.6 | 341.1 | 390.6 | 36.5 | 0.1 |
| Current Liabilities | |||||||
| Account Payables | 2.3 | 2.2 | 1.9 | 3.0 | 1.6 | 1.4 | 2.5 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0.7 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 |
| Other Current Liabilities | 10.7 | 0 | 4.0 | 3.5 | 2.2 | 0.6 | 0.1 |
| Total Current Liabilities | 13.1 | 8.5 | 9.6 | 10.8 | 5.3 | 2.3 | 3.7 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 45.5 | 0.0 |
| Total Non-Current Liabilities | 0.6 | 1.5 | 2.3 | 3.1 | 3.1 | 45.5 | 0.0 |
| Total Liabilities | 13.7 | 10.0 | 12.0 | 13.8 | 8.4 | 47.8 | 3.7 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (297.0) | (227.2) | (177.6) | (110.8) | (47.5) | (11.9) | (3.6) |
| Accumulated Other Comprehensive Income | 0.4 | 0.5 | 0.1 | (3.4) | (0.2) | 0.2 | 0 |
| Total Stockholders' Equity | 212.5 | 242.1 | 277.7 | 327.3 | 382.1 | (11.3) | (3.6) |
| Total Liabilities & Equity | 226.2 | 252.1 | 289.6 | 341.1 | 390.6 | 36.5 | 0.1 |
| Debt Metrics | |||||||
| Total Debt | 0.6 | 2.3 | 3.0 | 3.7 | 3.6 | 0 | 0.7 |
| Net Debt | (16.2) | (20.2) | (18.1) | (22.8) | (294.9) | (2.4) | 0.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (69.8) | (49.6) | (66.9) | (63.3) | (35.5) | (8.3) | (2.0) |
| Depreciation & Amortization | (2.6) | 0.6 | 0.5 | 0.4 | 0.1 | 0.0 | 0 |
| Stock-Based Compensation | 14.5 | 13.1 | 13.1 | 10.9 | 4.7 | 0.5 | 0 |
| Change in Working Capital | 3.1 | (1.0) | 0.7 | 2.0 | 1.4 | (0.8) | 1.8 |
| Other Non-Cash Items | 0.4 | (6.2) | (6.1) | (1.3) | (0.1) | (0.0) | 0.1 |
| Operating Cash Flow | (54.4) | (43.1) | (58.6) | (51.3) | (29.4) | (8.7) | (0.1) |
| Investing Activities | |||||||
| Capital Expenditure | (0.2) | (0.3) | (0.3) | (0.9) | (1.5) | (0.1) | 0 |
| Acquisitions | 0 | 0 | 0 | 0.0 | 0.1 | 0 | 0 |
| Purchases of Investments | (291.8) | (230.2) | (224.7) | (313.0) | (86.3) | (55.6) | 0 |
| Sales/Maturities of Investments | 314.9 | 274.5 | 277.5 | 92.9 | 34.2 | 22.1 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 |
| Investing Cash Flow | 22.9 | 44.0 | 52.5 | (221.0) | (53.6) | (33.6) | 0 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | (0.2) | 0.2 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | (0.4) | 0.2 | 0.0 | 0 |
| Financing Cash Flow | 25.7 | 0.5 | 0.7 | 0.2 | 379.2 | 44.5 | 0.2 |
| Cash Position | |||||||
| Net Change in Cash | (5.7) | 1.4 | (5.3) | (272.1) | 296.2 | 2.3 | 0.1 |
| Cash at Beginning | 22.6 | 21.2 | 26.5 | 298.6 | 2.4 | 0.1 | 0.0 |
| Cash at End | 16.9 | 22.6 | 21.2 | 26.5 | 298.6 | 2.4 | 0.1 |
| Free Cash Flow | (54.6) | (43.4) | (58.8) | (52.2) | (30.9) | (8.7) | (0.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Gross Profit | (0.6) | (0.6) | (0.5) | (0.5) | 0 | (0.0) | (0.0) |
| Operating Income | (79.5) | (62.4) | (78.2) | (67.6) | (35.8) | (8.6) | (1.9) |
| Net Income | (69.8) | (49.6) | (66.9) | (63.3) | (35.5) | (8.3) | (2.0) |
| EPS (Diluted) | -1.22 | -0.88 | -1.19 | -1.14 | -0.77 | -0.30 | -0.08 |
| Balance Sheet | |||||||
| Cash & Equivalents | 16.9 | 22.6 | 21.2 | 26.5 | 298.6 | 2.4 | 0.1 |
| Total Assets | 226.2 | 252.1 | 289.6 | 341.1 | 390.6 | 36.5 | 0.1 |
| Total Debt | 0.6 | 2.3 | 3.0 | 3.7 | 3.6 | 0 | 0.7 |
| Stockholders' Equity | 212.5 | 242.1 | 277.7 | 327.3 | 382.1 | (11.3) | (3.6) |
| Cash Flow | |||||||
| Operating Cash Flow | (54.4) | (43.1) | (58.6) | (51.3) | (29.4) | (8.7) | (0.1) |
| Capital Expenditure | (0.2) | (0.3) | (0.3) | (0.9) | (1.5) | (0.1) | 0 |
| Free Cash Flow | (54.6) | (43.4) | (58.8) | (52.2) | (30.9) | (8.7) | (0.1) |